Insights

For many early-career clinical researchers, trial design can feel rigid. A primary endpoint is selected, the study is powered around it, and success is determined by that single measure. But patients do not experience treatment effects through one outcome. They experience a combination of efficacy, side effects, symptoms, and quality of life. Reducing this to a single outcome can risk missing the bigger picture.

The need for diversity in clinical trials and the challenges of identifying patients who are unknown to the healthcare system complicate trial enrollment and add financial stress that may hinder the success of a study. A targeted, engineered approach to patient enrollment and diversity, using a financially calculable strategy, can ameliorate these challenges.